Answers are grounded in this paper and cite their sources.
Novel synthetic methods produce bioisosteric acylaminopyrazoles, suggesting promise for Ugi carboxamide mimetics.
This study reports a novel and efficient synthetic method for accessing di‐ and tri‐ substituted α‐acylaminopyrazole scaffolds, potential bioisosteric replacements for Ugi α‐acylamino carboxamide scaffolds. A diverse library of these α‐acylaminopyrazoles was generated via a Cu(II)‐catalyzed sequential Iqbal MCR/Knorr heterocyclization at room temperature. This two‐step protocol consistently yielded products in moderate‐to‐good yields and purity, eliminating the need for column chromatography. In silico ADME predictions further support their potential as bioisosteric replacements and suggest promising oral bioavailability.
No takes yet. Share an insight, caveat, or question.
Sini et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: